Kovanaze FDA Approval History
FDA Approved: Yes (First approved June 29, 2016)
Brand name: Kovanaze
Generic name: oxymetazoline hydrochloride and tetracaine hydrochloride
Dosage form: Nasal Spray
Company: St. Renatus LLC
Treatment for: Local Anesthesia
Kovanaze (oxymetazoline hydrochloride and tetracaine hydrochloride) is a vasoconstrictor and local anesthetic combination administered intranasally as a topical anesthetic for use in restorative dental procedures.
Development timeline for Kovanaze
| Date | Article |
|---|---|
| Jul 12, 2016 | Approval St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
